This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Sexually Transmitted Diseases  • Dermatology  • Dermatologic Disorders  • Herpes  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Jeffrey P. Engel, MD

JAMA. 1998;280:928-929.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Herpes simplex virus (HSV) is a member of the Herpesviridae family, a diverse group of double-stranded DNA, lipid-enveloped virions responsible for a wide variety of common human infections. Herpes simplex virus types 1 and 2 and the closely related varicella-zoster virus (VZV) make up the Alphaherpesvirinae virus subfamily. Infections caused by Alphaherpes virus are characterized by mucoepidermal and neural tropism and result in the typical clinical presentations of vesicular lesions and sensory nerve involvement and latency within dorsal root ganglia. Herpes simplex virus type 1 is most frequently associated with nongenital disease, while HSV type 2 is responsible for 90% of urogenital disease. Genital HSV is one of the most common sexually transmitted diseases in the United States, with HSV type 2 seropositivity detected in approximately 1 of 5 persons 12 years of age or older.¹

Following primary infection, HSV replicates at the site of inoculation . . . [Full Text of this Article]

From the Department of Medicine, East Carolina University School of Medicine, Greenville, NC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Treatment of Herpes Simplex Infections: An Evidence-Based Review
Cernik et al.
Arch Intern Med 2008;168:1137-1144.
ABSTRACT | FULL TEXT  

Prevention of Herpes Simplex Virus Eye Disease: A Cost-effectiveness Analysis
Lairson et al.
Arch Ophthalmol 2003;121:108-112.
ABSTRACT | FULL TEXT  

Oral Acyclovir for Herpes Simplex Virus Eye Disease: Effect on Prevention of Epithelial Keratitis and Stromal Keratitis
Herpetic Eye Disease Study Group
Arch Ophthalmol 2000;118:1030-1036.
ABSTRACT | FULL TEXT  

Antiviral Therapies for Long-term Suppression of Genital Herpes
Wald et al.
JAMA 1999;281:1169-1170.
FULL TEXT  

Another Antiviral Agent for Suppression of Genital Herpes: Famciclovir
JWatch Infect. Diseases 1998;1998:4-4.
FULL TEXT